HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 2 filers reported holding HORIZON PHARMA PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 5.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $118,000 | -39.5% | 4,500 | -55.9% | 0.01% | -36.8% |
| Q4 2018 | $195,000 | -31.1% | 10,200 | -30.6% | 0.02% | -5.0% |
| Q3 2018 | $283,000 | +10.5% | 14,700 | -6.4% | 0.02% | 0.0% |
| Q2 2018 | $256,000 | -14.1% | 15,700 | -25.9% | 0.02% | -23.1% |
| Q1 2018 | $298,000 | -13.6% | 21,200 | -49.4% | 0.03% | +85.7% |
| Q4 2017 | $345,000 | -34.9% | 41,928 | -38.7% | 0.01% | -30.0% |
| Q3 2017 | $530,000 | -5.7% | 68,450 | -19.0% | 0.02% | -4.8% |
| Q2 2017 | $562,000 | -35.0% | 84,531 | -66.4% | 0.02% | -41.7% |
| Q1 2017 | $864,000 | -67.8% | 251,474 | -62.3% | 0.04% | -62.9% |
| Q4 2016 | $2,683,000 | -13.2% | 666,565 | +87.5% | 0.10% | -30.2% |
| Q3 2016 | $3,091,000 | +156.9% | 355,484 | +146.6% | 0.14% | +124.2% |
| Q2 2016 | $1,203,000 | +30.1% | 144,130 | +17.5% | 0.06% | +1.6% |
| Q1 2016 | $925,000 | -12.8% | 122,686 | -54.2% | 0.06% | +3.4% |
| Q4 2015 | $1,061,000 | – | 267,865 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $59,421,000 | 38.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,259,875 | $425,908,000 | 14.19% |
| Broadfin Capital, LLC | 4,815,807 | $167,301,000 | 8.99% |
| JW Asset Management, LLC | 766,724 | $26,636,000 | 8.10% |
| Marble Arch Investments | 1,888,000 | $65,589,000 | 5.65% |
| HealthCor Management, L.P. | 3,200,000 | $111,168,000 | 5.60% |
| Beach Point Capital Management LP | 794,290 | $27,594,000 | 5.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,325,829 | $115,539,000 | 4.52% |
| Ratan Capital Management LP | 1,321,300 | $45,902,000 | 4.37% |
| Green Owl Capital Management, LLC | 130,000 | $4,516,000 | 3.22% |